Novel insights into the implication of the IGF-1 network in prostate cancer
- 28 February 2005
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 11 (2) , 52-55
- https://doi.org/10.1016/j.molmed.2004.12.005
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- IGF‐1 and Prostate CancerPublished by Wiley ,2004
- High Levels of Circulating Insulin-Like Growth Factor-I Increase Prostate Cancer Risk: A Prospective Study in a Population-Based Nonscreened CohortJournal of Clinical Oncology, 2004
- Cancer genes and the pathways they controlNature Medicine, 2004
- Insulin-like growth factors and neoplasiaNature Reviews Cancer, 2004
- Combination of Somatostatin Analog, Dexamethasone, and Standard Androgen Ablation Therapy in Stage D3 Prostate Cancer Patients with Bone MetastasesClinical Cancer Research, 2004
- Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysisPublished by Elsevier ,2004
- PTEN inhibits cell proliferation and induces apoptosis by downregulating cell surface IGF-IR expression in prostate cancer cellsOncogene, 2004
- Activation of Pro-apoptotic p38-MAPK Pathway in the Prostate Cancer Cell Line M12 Expressing a Truncated IGF-IRHormone and Metabolic Research, 2003
- The IGF‐1 receptor in cancer biologyInternational Journal of Cancer, 2003
- Chemosensitization of human prostate cancer using antisense agents targeting the type 1 insulin‐like growth factor receptorBJU International, 2003